ClinicalTrials.Veeva

Menu

Human Irisin Concentration in Sarcopenia

K

Korea University

Status

Completed

Conditions

Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT01874912
SO(IRISIN)

Details and patient eligibility

About

Irisin has been identified as a novel myokine that drives brown-fat-like conversion of white adipose tissue. In this cross-sectional study, the researches investigated whether serum irisin levels are decreased in patients with sarcopenia compared with control subjects with normal muscle mass, and assessed the association between serum irisin levels and various metabolic parameters.

Enrollment

406 patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 20<age<80
  • apparently healthy subjects

Exclusion criteria

  • a history of cardiovascular disease
  • diabetes
  • stage 2 hypertension
  • malignancy
  • severe renal or hepatic disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems